Evidence-first essays on GLP-1s, obesity medicine, cardiometabolic health, and the systems that deliver care — published twice weekly.
Twice-weekly clinical commentary on GLP-1s, obesity medicine, and cardiometabolic health — written for clinicians, operators, and readers who want substance over noise.
Subscribe Free →No spam, ever. Unsubscribe in one click.
Selected writing from before Substance Over Noise — published on Medium and preserved here for reference.